Enhancement of anti-tumor immune responses by transfection of IFNγ gene into tumor using a novel type synthetic vector

Veterinary Immunology and Immunopathology

Volumn 162, Issue 1-2, 2014, Pages 59-64

  Wijesekera, Daluthgamage Patsy H ^a   Sugiura, Kikuya ^a   Yuba, Eiji ^a   Ueda, Kana ^a   Wijewardana, Viskam ^a   Kanegi, Ryouji ^a   Nishimura, Toshiya ^a   Ushigusa, Takahiro ^a   Hatoya, Shingo ^a   Kono, Kenji ^a   Inaba, Toshio ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Anti tumor effect; Dendritic cells; Gene transfection; IFN ; Synthetic vector

Indexed keywords

GAMMA INTERFERON; POLYAMIDOAMINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPATHOGENIC EFFECT; DENDRITIC CELL; DOG; EXPRESSION VECTOR; GENETIC TRANSFECTION; IMMUNE RESPONSE; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; SYNTHETIC VECTOR; TH1 CELL; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; ADENOCARCINOMA; ADMINISTRATION AND DOSAGE; ANIMAL; CELL GROWTH; CYTOTOXICITY TEST; DOG DISEASE; FEMALE; GENE VECTOR; GENETICS; IMMUNOLOGY; OSTEOSARCOMA; PATHOLOGY; THYROID TUMOR; TUMOR CELL LINE; VETERINARY;

ADENOCARCINOMA; ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; DOG DISEASES; DOGS; FEMALE; GENETIC VECTORS; INTERFERON-GAMMA; OSTEOSARCOMA; THYROID NEOPLASMS; TRANSFECTION;

EID: 84910087756     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2014.08.016     Document Type: Article

References (25)

1. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005, 5:296-306.
2. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7297-7301.
3. De Vries I.J.M., Lesterhuis W.J., Scharenborg N.M., Engelen L.P.H., Ruiter D.J., Gerritsen M.-J.P., Croockewit S., Britten C.M., Torensma R., Adema G.J., Figdor C.G., Punt C.J.A. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin. Cancer Res. 2003, 9:5091-50100.
4. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 2001, 193:233-238.
5. Fanger N.A., Maliszewski C.R., Schooley K., Griffith T.S. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med. 1999, 190:1155-1164.
6. Gao Q., Qiu S.-J., Fan J., Zhou J., Wang X.-Y., Xiao Y.-S., Xu Y., Li Y.-W., Tang Z.-Y. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 2007, 25:2586-2593.
7. Hanna E., Quick J., Libutti S.K. The tumor microenvironment: a novel target for cancer therapy. Oral Dis. 2009, 15:8-17.
8. Kasza L. Establishment and characterization of canine thyroid adenocarcinoma and canine melanoma cell lines. Am. J. Vet. Res. 1964, 25:1178-1185.
9. Kono K., Ikeda R., Tsukamoto K., Yuba E., Kojima C., Harada A. Polyamidoamine dendron-bearing lipids as a non-viral vector: influence of dendron generation. Bioconj. Chem. 2012, 23:871-879.
10. Mito K., Sugiura K., Ueda K., Hori T., Akazawa T., Yamate J., Nakagawa H., Hatoya S., Inaba M., Inoue N., Ikehara S., Inaba T. IFNγ markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models. Cancer Res. 2010, 70:7093-70101.
11. Mitra S., Stemke-Hale K., Mills G.B., Claerhout S. Interactions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapy. Cancer Sci. 2012, 103:400-407.
12. Pedersen L.G., Castelruiz Y., Jacobsen S., Aasted B. Identification of monoclonal antibodies that cross-react with cytokines from different animal species. Vet. Immunol. Immunopathol. 2002, 88:111-122.
13. Riggs J.L., McAllister R.M., Lennette E.H. Immunofluorescent studies of RD-114 virus replication in cell culture. J. Gen. Virol. 1974, 25:21-29.
14. Sakaguchi N., Kojima C., Harada A., Koiwai K., Shimizu K., Emi N., Kono K. Generation of highly potent nonviral gene vectors by complexation of lipoplexes and transferrin-bearing fusogenic polymer-modified liposomes in aqueous glucose solution. Biomaterials 2008, 29:1262-1272.
15. Sato E., Olson S.H., Ahn J., Bundy B., Nishikawa H., Qian F., Jungbluth A.A., Frosina D., Gnjatic S., Ambrosone C., Kepner J., Odunsi T., Ritter G., Lele S., Chen Y.-T., Ohtani H., Old L.J., Odunsi K. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 2005, 2:18538-18543.
16. Schmitz M., Zhao S., Deuse Y., Schäkel K., Wehner R., Wöhner H., Hölig K., Wienforth F., Kiessling A., Bornhäuser M., Temme A., Rieger M.A., Weigle B., Bachmann M., Rieber E.P. Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity. J. Immunol. 2005, 174:4127-4134.
17. Sonawane N.D., Szoka F.C., Verkman A.S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 2003, 278:44826-44831.
18. Sugiura K., Akazawa T., Fujimoto M., Wijewardana V., Mito K., Hatoya S., Taketani S., Komori M., Inoue N., Inaba T. Construction of an expression vector for improved secretion of canine IL-18. Vet. Immunol. Immunopathol. 2008, 126:388-391.
19. Takahashi T., Harada A., Emi N., Kono K. Preparation of efficient gene carriers using a polyamidoamine dendron-bearing lipid: improvement of serum resistance. Bioconj. Chem. 2005, 16:1160-1165.
20. Takahashi T., Kono K., Itoh T., Emi N., Takagishi T. Synthesis of novel cationic lipids having polyamidoamine dendrons and their transfection activity. Bioconj. Chem. 2003, 14:764-773.
21. Thakur A., Schalk D., Sarkar S.H., Al-Khadimi Z., Sarkar F.H., Lum L.G. A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells. Cancer Immunol. Immunother. 2012, 61:497-509.
22. Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 2003, 4:346-358.
23. Wijewardana V., Sugiura K., Oichi T., Fujimoto M., Akazawa T., Hatoya S., Inaba M., Ikehara S., Jayaweera T.S.P., Inaba T. Generation of canine dendritic cells from peripheral blood monocytes without using purified cytokines. Vet. Immunol. Immunopathol. 2006, 114:37-48.
24. Yang R., Xu D., Zhang A., Gruber A. Immature dendritic cells kill ovarian carcinoma cells by a FAS/FASL pathway, enabling them to sensitize tumor-specific CTLs. Int. J. Cancer 2001, 94:407-413.
25. Yuba E., Nakajima Y., Tsukamoto K., Iwashita S., Kojima C., Harada A., Kono K. Effect of unsaturated alkyl chains on transfection activity of poly(amidoamine) dendron-bearing lipids. J. Control. Release 2012, 160:552-560.